PROM1 and ovarian carcinoma: Further, several studies detected the expression of CD133 in ovarian cancer cells of different origins [18-20], suggesting that CD133 expression in ovarian cancer is directly regulated by epigenetic modifications and that CD133 is a candidate marker of ovarian cancer stem cells.